Patents by Inventor Jiunn H. Lin

Jiunn H. Lin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination therapy for the treatment of AIDS
    Patent number: 6180634
    Abstract: The combination of the HIV protease inhibitor Compound A and one or more nucleoside reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors, or protease inhibitors is useful in the inhibition of HIV protease, the inhibition of HIV reverse transcriptase, the prevention or treatment of AIDS, either as compounds, pharmaceutically acceptable salts or esters, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.
    Type: Grant
    Filed: November 13, 1998
    Date of Patent: January 30, 2001
    Assignee: Merck & Co., Inc.
    Inventors: Joseph P. Vacca, Jiunn H. Lin, Kuang C. Yeh, Paul J. Deutsch, William D. Ju, Jeffrey A. Chodakewitz
  • 7-chloro-5,6-di hydro-3-(5-(1,2-dihydroxy-isopropyl)-1,2,4-oxadiazol-3-yl)-5-methyl-6-oxo -4H-imidazo[1,5A][1,4]benzodiazepine
    Patent number: 4939139
    Abstract: A metabolite of the known anxiolytic agent, 7-chloro-5,6-dihydro-3-(5-isopropyl-1,2,4-oxadiazol-3-yl)-5-methyl-6-oxo-4 H-i midazo[1,5a][1,4]benzodiazepine is a 1,2-dihydroxy derivative of the isopropyl moiety and is itself an anxiolytic agent of greater activity than its substrate.
    Type: Grant
    Filed: July 26, 1989
    Date of Patent: July 3, 1990
    Assignee: Merck & Co., Inc.
    Inventors: Jiunn H. Lin, Harri G. Ramjit, Steven M. Pitzenberger, Edgar H. Ulm
  • 7-chloro-5,6-dihydro-3-(5-(2-hydroxy-isoprop yl)-1,2,4-oxadiazol-3-yl)-5-methyl-6-oxo-4H-imidazo[1,5a][1,4]benzodiazep ine
    Patent number: 4904654
    Abstract: A metabolite of the known anxiolytic agent, 7-chloro-5,6-dihydro-3-(5-isopropyl-1,2,4-oxadiazol-3-yl)-5-methyl-6-oxo-4 H- imidazo[1,5a][1,4]benzodiazepine is a 2-hydroxy derivative of the isopropyl moiety and is itself an anxiolytic agent.
    Type: Grant
    Filed: July 26, 1989
    Date of Patent: February 27, 1990
    Assignee: Merck & Co., Inc.
    Inventors: Jiunn H. Lin, Steven M. Pitzenberger, Harri G. Ramjit, Edgar H. Ulm